Bio-Rad Laboratories (BIO) Long-Term Deferred Tax (2016 - 2019)
Historic Long-Term Deferred Tax for Bio-Rad Laboratories (BIO) over the last 9 years, with Q4 2019 value amounting to $138.0 million.
- Bio-Rad Laboratories' Long-Term Deferred Tax rose 8086.5% to $138.0 million in Q4 2019 from the same period last year, while for Dec 2019 it was $138.0 million, marking a year-over-year increase of 8086.5%. This contributed to the annual value of $138.0 million for FY2019, which is 8086.5% up from last year.
- As of Q4 2019, Bio-Rad Laboratories' Long-Term Deferred Tax stood at $138.0 million, which was up 8086.5% from $76.3 million recorded in Q4 2018.
- In the past 5 years, Bio-Rad Laboratories' Long-Term Deferred Tax registered a high of $138.0 million during Q4 2019, and its lowest value of $76.3 million during Q4 2018.
- Over the past 5 years, Bio-Rad Laboratories' median Long-Term Deferred Tax value was $99.5 million (recorded in 2015), while the average stood at $102.2 million.
- Its Long-Term Deferred Tax has fluctuated over the past 5 years, first crashed by 3276.74% in 2017, then surged by 8086.5% in 2019.
- Bio-Rad Laboratories' Long-Term Deferred Tax (Quarter) stood at $99.5 million in 2015, then rose by 18.39% to $117.8 million in 2016, then plummeted by 32.77% to $79.2 million in 2017, then fell by 3.66% to $76.3 million in 2018, then skyrocketed by 80.87% to $138.0 million in 2019.
- Its Long-Term Deferred Tax stands at $138.0 million for Q4 2019, versus $76.3 million for Q4 2018 and $79.2 million for Q4 2017.